Clinical Trials Browser

Phase 2 × Neoplastic Cells, Circulating × eribulin × Clear all

NCT02035813 2024-06-04

DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

Phase 2 Completed

Breast Neoplasms, Neoplastic Cells, Circulating